Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last €48.07 EUR
Change Today -1.25 / -2.53%
Volume 113.0
MRK On Other Exchanges
New York
EN Paris
Sao Paulo
As of 8:40 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Bruce N. Kuhlik

AgeTotal Calculated CompensationThis person is connected to 0 board members in 0 different organizations across 1 different industries.

As of Fiscal Year 2014


Mr. Bruce N. Kuhlik served as an Executive Vice President and General Counsel of Merck & Co. Inc. since January 2008 and August 1, 2007 respectively until June 30, 2015. Mr. Kuhlik was responsible for Merck's legal and public affairs functions. He served as Senior Vice President of Merck & Co. Inc. form August 1, 2007 to January 2008. Mr. Kuhlik joined Merck in 2005 and served as Vice President and Associate General Counsel, where he was responsible for its VIOXX litigation ...

Read Full Background

Corporate Headquarters*

2000 Galloping Hill Road
Kenilworth, New Jersey 07033

United States

Phone: 908-740-4000
Fax: --

Board Members Memberships*

There is no Board Members Memberships data available.


BA 1978
Harvard College
JD 1981
Harvard Law School

Other Affiliations*

Annual Compensation*

Total Annual Compensation$807,492

Stock Options*

Restricted Stock Awards$2,798,568
All Other Compensation$71,192
Exercised Options195,225
Exercised Options Value$2,949,235
Exercisable Options206,284
Exercisable Options Value$3,451,225
Unexercisable Options281,377
Unexercisable Options Value$2,147,546
Total Value of Options$8,548,006
Total Number of Options682,886

Total Compensation*

Total Annual Cash Compensation$1,914,292
Total Short Term Compensation$807,492
Other Long Term Compensation$2,869,760
Total Calculated Compensation$6,172,882
*Data is at least as current as the most recent Definitive Proxy.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MRK:FP €48.07 EUR -1.25


Robert A. Bradway Chairman, Chief Executive Officer, President, Chairman of Executive Committee and Member of Equity Award Committee
Amgen Inc.
John C. Martin Ph.D.Chairman and Chief Executive Officer
Gilead Sciences Inc.
Brenton L. Saunders J.D.Chief Executive Officer, President and Director
Allergan plc
Marijn E. Dekkers Ph.D.Chairman of Management Board and Chief Executive Officer
Bayer AG
Inge G. Thulin Chairman, Chief Executive Officer and President
3M Company
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MERCK & CO. INC., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at